(Bloomberg) -- A group of lenders including Goldman Sachs Group Inc. are preparing €1.1 billion ($1.2 billion) of leveraged financing to back CVC Capital Partners Plc’s buyout of CompuGroup Medical SE & Co. KGaA, according to people familiar with the matter.
Goldman, UBS Group AG and Deutsche Bank AG are planning to syndicate the term loan B to a wider group of lenders in the first quarter, the people said.
CVC offered to take CompuGroup private in December in a deal that values the German software provider to healthcare at €1.18 billion. The European buyout firm bid €22 a share in cash for the company, and agreed to a strategic partnership with CompuGroup’s majority shareholder around the founding Gotthardt family, which plans to retain a roughly 50.1% interest.
Green shoots for leveraged buyout financing are starting to emerge after years of sluggish dealflow. Banks have also lined up loans to back the purchase of a stake in French drugmaker Sanofi SA and around €9 billion for Unilever Plc’s ice cream business, in case it opts for a sale to private equity firms instead of a public listing.
Spokespeople for CVC and CompuGroup declined to comment, as did a representative for UBS. Requests for comment to Goldman Sachs and Deutsche Bank weren’t immediately returned.
CVC has been ramping up deals after raising €26 billion in 2023 for the world’s biggest-ever buyout fund. The firm deployed €13.4 billion through June 2024.
Frank Gotthardt created CompuGroup in 1987 as a computer science student and listed the company in 2007. He and his dentist wife, Brigitte Gotthardt, and their doctor son, Daniel Gotthardt, as well as a related shareholder, Reinhard Koop, own a majority.
©2025 Bloomberg L.P.